XENON XE 127
LOE Approachingxenon xe-127
NDAINHALATIONGAS
Approved
Oct 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon XE-127 is an inhaled xenon gas approved since 1982 for diagnostic and therapeutic applications. The exact clinical indications are not fully specified in available data, but xenon gas is typically used in medical imaging and anesthesia applications. This is a unique gaseous modality with a long regulatory history.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting a consolidating commercial team preparing for generic entry.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xenon XE-127 involves 29 linked career positions with emphasis on director-level and executive roles across commercial and R&D functions. This is a mature-stage product where career advancement is driven by business acumen, cost management, and organizational leadership rather than product innovation.
Director/Senior DirectorDirector
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.